![Results from a multicenter, open-label, pivotal phase II study of chidamide in relapsed or refractory peripheral T-cell lymphoma - Annals of Oncology Results from a multicenter, open-label, pivotal phase II study of chidamide in relapsed or refractory peripheral T-cell lymphoma - Annals of Oncology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/asset/d8d55bc3-f2fb-4822-9703-9bf54077d524/gr1.jpg)
Results from a multicenter, open-label, pivotal phase II study of chidamide in relapsed or refractory peripheral T-cell lymphoma - Annals of Oncology
![IFN-β Inhibits T Cell Activation Capacity of Central Nervous System APCs | The Journal of Immunology IFN-β Inhibits T Cell Activation Capacity of Central Nervous System APCs | The Journal of Immunology](https://www.jimmunol.org/sites/default/files/highwire/jimmunol/177/6.cover-source.jpg)
IFN-β Inhibits T Cell Activation Capacity of Central Nervous System APCs | The Journal of Immunology
![Comprehensive analysis of peripheral T-cell and natural killer/T-cell lymphoma in Asian patients: A multinational, multicenter, prospective registry study in Asia - The Lancet Regional Health – Western Pacific Comprehensive analysis of peripheral T-cell and natural killer/T-cell lymphoma in Asian patients: A multinational, multicenter, prospective registry study in Asia - The Lancet Regional Health – Western Pacific](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/c56ef5e0-f1a0-48bb-b536-b245c8be0246/gr1.jpg)
Comprehensive analysis of peripheral T-cell and natural killer/T-cell lymphoma in Asian patients: A multinational, multicenter, prospective registry study in Asia - The Lancet Regional Health – Western Pacific
![PDF) Grow With the Challenge – Microbial Effects on Epithelial Proliferation, Carcinogenesis, and Cancer Therapy PDF) Grow With the Challenge – Microbial Effects on Epithelial Proliferation, Carcinogenesis, and Cancer Therapy](https://i1.rgstatic.net/publication/327784096_Grow_With_the_Challenge_-_Microbial_Effects_on_Epithelial_Proliferation_Carcinogenesis_and_Cancer_Therapy/links/5ba44f38a6fdccd3cb676159/largepreview.png)
PDF) Grow With the Challenge – Microbial Effects on Epithelial Proliferation, Carcinogenesis, and Cancer Therapy
![The relationship between neutrophil to lymphocyte ratio, endothelial function, and severity in patients with obstructive sleep apnea - Journal of Cardiology The relationship between neutrophil to lymphocyte ratio, endothelial function, and severity in patients with obstructive sleep apnea - Journal of Cardiology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/2048585804/2058424981/gr1.jpg)
The relationship between neutrophil to lymphocyte ratio, endothelial function, and severity in patients with obstructive sleep apnea - Journal of Cardiology
![Skin-resident natural killer T cells participate in cutaneous allergic inflammation in atopic dermatitis - Journal of Allergy and Clinical Immunology Skin-resident natural killer T cells participate in cutaneous allergic inflammation in atopic dermatitis - Journal of Allergy and Clinical Immunology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/4bfe347f-2560-4b78-84a9-4f060f5b805e/gr5_lrg.jpg)
Skin-resident natural killer T cells participate in cutaneous allergic inflammation in atopic dermatitis - Journal of Allergy and Clinical Immunology
![The ECHELON-2 Trial: 5-year results of a randomized, phase III study of brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma☆ - Annals of Oncology The ECHELON-2 Trial: 5-year results of a randomized, phase III study of brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma☆ - Annals of Oncology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/decbddbc-c725-43a9-b0ef-34cf810a2fd2/gr1.jpg)
The ECHELON-2 Trial: 5-year results of a randomized, phase III study of brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma☆ - Annals of Oncology
![Frontiers | Characterization of the Tumor Immune Microenvironment in Lung Squamous Cell Carcinoma Using Imaging Mass Cytometry | Oncology Frontiers | Characterization of the Tumor Immune Microenvironment in Lung Squamous Cell Carcinoma Using Imaging Mass Cytometry | Oncology](https://www.frontiersin.org/files/Articles/620989/fonc-11-620989-HTML/image_m/fonc-11-620989-g001.jpg)
Frontiers | Characterization of the Tumor Immune Microenvironment in Lung Squamous Cell Carcinoma Using Imaging Mass Cytometry | Oncology
![Pathogenetic and diagnostic significance of microRNA deregulation in peripheral T-cell lymphoma not otherwise specified | Blood Cancer Journal Pathogenetic and diagnostic significance of microRNA deregulation in peripheral T-cell lymphoma not otherwise specified | Blood Cancer Journal](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fbcj.2014.78/MediaObjects/41408_2014_Article_BFbcj201478_Fig1_HTML.jpg)
Pathogenetic and diagnostic significance of microRNA deregulation in peripheral T-cell lymphoma not otherwise specified | Blood Cancer Journal
![Frontiers | IFN-I Mediates Dysfunction of Endothelial Progenitor Cells in Atherosclerosis of Systemic Lupus Erythematosus | Immunology Frontiers | IFN-I Mediates Dysfunction of Endothelial Progenitor Cells in Atherosclerosis of Systemic Lupus Erythematosus | Immunology](https://www.frontiersin.org/files/Articles/581385/fimmu-11-581385-HTML/image_m/fimmu-11-581385-g001.jpg)
Frontiers | IFN-I Mediates Dysfunction of Endothelial Progenitor Cells in Atherosclerosis of Systemic Lupus Erythematosus | Immunology
![Targeting cytokines and immune checkpoints in atherosclerosis with monoclonal antibodies - Atherosclerosis Targeting cytokines and immune checkpoints in atherosclerosis with monoclonal antibodies - Atherosclerosis](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/49373608-48f3-4c28-9fd8-5eb93f2f3b70/ga1_lrg.jpg)
Targeting cytokines and immune checkpoints in atherosclerosis with monoclonal antibodies - Atherosclerosis
![Effect of adoptive T-cell immunotherapy on immunological parameters and prognosis in patients with advanced pancreatic cancer - Cytotherapy Effect of adoptive T-cell immunotherapy on immunological parameters and prognosis in patients with advanced pancreatic cancer - Cytotherapy](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/e85931f6-d207-41fa-ac7d-cba9f9427aac/gr6_lrg.jpg)
Effect of adoptive T-cell immunotherapy on immunological parameters and prognosis in patients with advanced pancreatic cancer - Cytotherapy
![Effect of adoptive T-cell immunotherapy on immunological parameters and prognosis in patients with advanced pancreatic cancer - Cytotherapy Effect of adoptive T-cell immunotherapy on immunological parameters and prognosis in patients with advanced pancreatic cancer - Cytotherapy](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/460e3ce3-72c7-4555-a7b9-2af9dcf535eb/gr5.jpg)
Effect of adoptive T-cell immunotherapy on immunological parameters and prognosis in patients with advanced pancreatic cancer - Cytotherapy
![References in Panobinostat in combination with bortezomib in patients with relapsed or refractory peripheral T-cell lymphoma: an open-label, multicentre phase 2 trial - The Lancet Haematology References in Panobinostat in combination with bortezomib in patients with relapsed or refractory peripheral T-cell lymphoma: an open-label, multicentre phase 2 trial - The Lancet Haematology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/359eb55e-fa69-4eeb-bf3e-65395a5425e5/gr1_lrg.jpg)
References in Panobinostat in combination with bortezomib in patients with relapsed or refractory peripheral T-cell lymphoma: an open-label, multicentre phase 2 trial - The Lancet Haematology
![Phase I/II study of pralatrexate in Japanese patients with relapsed or refractory peripheral T‐cell lymphoma - Maruyama - 2017 - Cancer Science - Wiley Online Library Phase I/II study of pralatrexate in Japanese patients with relapsed or refractory peripheral T‐cell lymphoma - Maruyama - 2017 - Cancer Science - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/9c7744aa-1bee-486b-9b8e-11a8cc4e6fc1/cas13340-fig-0001-m.jpg)
Phase I/II study of pralatrexate in Japanese patients with relapsed or refractory peripheral T‐cell lymphoma - Maruyama - 2017 - Cancer Science - Wiley Online Library
![Invariant natural killer T-cell neutralization is a possible novel therapy for human eosinophilic esophagitis – topic of research paper in Biological sciences. Download scholarly article PDF and read for free on CyberLeninka Invariant natural killer T-cell neutralization is a possible novel therapy for human eosinophilic esophagitis – topic of research paper in Biological sciences. Download scholarly article PDF and read for free on CyberLeninka](https://cyberleninka.org/viewer_images/1019489/f/1.png)
Invariant natural killer T-cell neutralization is a possible novel therapy for human eosinophilic esophagitis – topic of research paper in Biological sciences. Download scholarly article PDF and read for free on CyberLeninka
![Comprehensive analysis of peripheral T-cell and natural killer/T-cell lymphoma in Asian patients: A multinational, multicenter, prospective registry study in Asia - The Lancet Regional Health – Western Pacific Comprehensive analysis of peripheral T-cell and natural killer/T-cell lymphoma in Asian patients: A multinational, multicenter, prospective registry study in Asia - The Lancet Regional Health – Western Pacific](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/asset/1451f4f6-d492-4e25-898e-ead2b3b31bc8/gr2.jpg)